Research Article
Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma
Table 4
First-line systemic therapy regimens and median time to treatment failure (TTF).
| Systemic therapy | | Median TTF (months) |
| Gemcitabine + docetaxel | 31 | 5.2 | Gemcitabine | 12 | 4.3 | Doxorubicin-alkylator combo | 20 | 3.1 | Liposomal doxorubicin | 12 | 2.9 | Doxorubicin | 6 | 3.3 | Alkylator, single | 3 | 1.8 | Tyrosine kinase inhibitors | 7 | 9.3 | Other combos | 13 | 7.2 | Other single agents | 9 | 1.6 |
|
|